Alembic
Ticker > Company >

Alembic share price

Alembic Ltd.

NSE: ALEMBICLTD BSE: 506235 SECTOR: Pharmaceuticals & Drugs  1.07 L   315   64

118.55
+1.45 (1.24%)
BSE: 10 Jul 04:01 PM

Price Summary

Today's High

₹ 119.65

Today's Low

₹ 117.15

52 Week High

₹ 169

52 Week Low

₹ 85.55

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 3044.15 Cr.

Enterprise Value

₹ 3054.41 Cr.

No. of Shares

25.68 Cr.

P/E

21.45

P/B

3.57

Face Value

₹ 2

Div. Yield

2.02 %

Book Value (TTM)

₹  33.23

CASH

₹ 4.19 Cr.

DEBT

₹ 14.45 Cr.

Promoter Holding

70.88 %

EPS (TTM)

₹  5.53

Sales Growth

40.79%

ROE

17.08 %

ROCE

18.25%

Profit Growth

52.82 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year40.79%
3 Year41.31%
5 Year23.81%

Profit Growth

1 Year52.82%
3 Year18.31%
5 Year8.7%

ROE%

1 Year17.08%
3 Year12.34%
5 Year9.68%

ROCE %

1 Year18.25%
3 Year13.35%
5 Year10.64%

Debt/Equity

0.0169

Price to Cash Flow

37.57

Interest Cover Ratio

84.0632

CFO/PAT (5 Yr. Avg.)

0.285784472345378

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 70.88 0.00
Dec 2024 70.88 0.00
Sep 2024 70.88 0.00
Jun 2024 70.88 0.00
Mar 2024 70.88 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 18.3106221807773% for the Past 3 years.
  • The company has shown a good revenue growth of 41.3054628889372% for the Past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 84.0632.
  • The Company has been maintaining an effective average operating margins of 28.1068107250428% in the last 5 years.
  • Company’s PEG ratio is 0.406051976950574.
  • The company has an efficient Cash Conversion Cycle of 49.0158 days.
  • The company has a high promoter holding of 70.88%.

 Limitations

  • Tax rate is low at 6.607.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 47.51 49.08 51.1 55.97 58.22
Total Expenditure 24.14 29.63 32.72 30.25 32.21
Operating Profit 23.37 19.45 18.38 25.72 26.01
Other Income 1.95 1.89 65.59 4.24 2.78
Interest 0.33 0.34 0.51 0.52 0.45
Depreciation 1.38 2.41 2.59 2.59 2.66
Exceptional Items 0 0 0 0 0
Profit Before Tax 23.61 18.59 80.87 26.85 25.68
Tax 2.93 1.75 4.27 1.16 2.85
Profit After Tax 20.68 16.84 76.6 25.69 22.83
Adjusted EPS (Rs) 0.81 0.66 2.98 1 0.89

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 72.3 75.97 123.16 152.25 214.36
Total Expenditure 62.21 63.06 85.15 96 124.8
Operating Profit 10.09 12.92 38.01 56.25 89.55
Other Income 10.61 89.09 64.11 54.62 74.51
Interest 0.27 0.23 0.16 0.69 1.83
Depreciation 3.91 4.5 6.36 7.46 10.24
Exceptional Items 0 0 -10.61 0 0
Profit Before Tax 16.52 97.28 85 102.72 151.99
Tax 3.15 11.56 5.73 9.83 10.04
Net Profit 13.36 85.71 79.27 92.89 141.95
Adjusted EPS (Rs.) 0.52 3.34 3.09 3.62 5.53

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 51.36 51.36 51.36 51.36 51.36
Total Reserves 775.46 962.49 777.63 757.4 801.83
Borrowings 0 0 0 7.39 10.67
Other N/C liabilities 51.24 63.45 38.12 40.54 37.69
Current liabilities 58.39 66.89 86.95 94.71 124.35
Total Liabilities 936.45 1144.19 954.06 951.4 1025.9
Assets
Net Block 133.69 133.5 131.83 130.54 135.33
Capital WIP 37.27 0.19 0.13 1.1 0
Intangible WIP 0 0 0 0 0
Investments 565.5 702.38 461.07 399.78 364.11
Loans & Advances 0.85 4.98 0 35 35
Other N/C Assets 99.53 162.9 187.96 245.94 279.09
Current Assets 99.62 140.23 173.07 139.05 212.38
Total Assets 936.45 1144.19 954.06 951.4 1025.9
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 16.52 97.28 85 102.72 151.99
Adjustment 1.54 -79.16 -53.46 -42.82 -53.74
Changes in Assets & Liabilities -17.22 -31.35 9.59 -36.22 -2.71
Tax Paid -1.95 -8.64 -6.43 1.65 -14.51
Operating Cash Flow -1.12 -21.87 34.7 25.33 81.03
Investing Cash Flow -35.15 22.66 11.29 22.6 -21.79
Financing Cash Flow -15.27 -5.66 -46.08 -47.77 -57.7
Net Cash Flow -51.53 -4.86 -0.09 0.16 1.54

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 70.88 70.88 70.88 70.88 70.88
chirayu ramanbhai amin 3.24 3.24 3.24 3.24 3.24
inaaya shaunak amin 0.02 0.02 0.02 0.02 0.02
malika chirayu amin 2.99 2.99 2.99 2.99 2.99
naintara shaunak amin 0.02 0.02 0.02 0.02 0.02
nirayu limited 63.06 63.06 63.06 63.06 63.06
pranav chirayu amin 0.75 0.75 0.75 0.75 0.75
ranvir pranav amin 0.02 0.02 0.02 0.02 0.02
samira pranav amin 0.02 0.02 0.02 0.02 0.02
shaunak chirayu amin 0.75 0.75 0.75 0.75 0.75
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 29.12 29.12 29.12 29.12 29.12
investor education and pr... - 1.20 1.25 - 1.27
llp 0.03 0.04 0.06 0.05 0.06
investor education and pr... 1.20 - - 1.29 -

Annual Reports

Title Link
Title Link
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit ICRA
Credit ICRA
Credit ICRA
Credit ICRA
TYPE AGENCY Link
TYPE AGENCY Link
Research BOB Capital Market

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Alembic informs about newspaper publication 5 Jul, 2:31 PM Alembic submits BRSR 4 Jul, 4:34 PM Alembic informs about press release 16 May, 4:57 PM Alembic - Quaterly Results 13 May, 5:30 PM Alembic - Quaterly Results 13 May, 5:30 PM Alembic - Quaterly Results 13 May, 5:30 PM Alembic informs about completion of tenure of independent director 25 Feb, 10:28 AM Alembic - Quaterly Results 7 Feb, 5:50 PM Alembic - Quaterly Results 7 Feb, 5:50 PM Alembic - Quaterly Results 7 Feb, 5:50 PM Alembic reports 50% rise in Q2 consolidated net profit 9 Nov, 3:07 PM Alembic - Quaterly Results 8 Nov, 5:03 PM Alembic - Quaterly Results 8 Nov, 5:03 PM Alembic informs about board meeting 29 Oct, 11:55 AM Alembic - Quaterly Results 12 Aug, 3:55 PM Alembic - Quaterly Results 12 Aug, 3:55 PM Alembic - Quaterly Results 12 Aug, 3:55 PM Alembic informs about loss of share certificate 26 Jul, 12:30 PM Alembic informs about annual report 11 Jul, 5:08 PM Alembic informs about record date 11 Jul, 4:43 PM Alembic informs about loss of share certificates 18 Jun, 5:28 PM Alembic informs about loss of share certificate 6 Jun, 1:07 PM Alembic informs about loss of share certificate 25 May, 10:30 AM Alembic informs about postal ballot notice 24 May, 12:16 PM Alembic reports over 4-fold jump in Q4 consolidated net profit 14 May, 2:18 PM Alembic - Quaterly Results 13 May, 6:32 PM Alembic - Quaterly Results 13 May, 6:32 PM Alembic informs about loss of share certificates 6 May, 2:36 PM Alembic informs about loss of share certificate 16 Apr, 12:14 PM Alembic informs about details of loss of certificate 6 Apr, 3:32 PM Alembic informs about loss of share certificate 1 Apr, 5:02 PM Alembic informs about loss of share certificate 27 Feb, 2:28 PM Alembic informs about loss of share certificate 24 Feb, 11:07 AM Alembic informs about loss of share certificate 22 Feb, 2:04 PM Alembic submits unaudited financial results 14 Feb, 5:19 PM Alembic - Quaterly Results 14 Feb, 4:54 PM Alembic - Quaterly Results 14 Feb, 4:54 PM Alembic informs about loss of share certificate 16 Jan, 4:48 PM Alembic informs about loss of share certificate 9 Jan, 3:53 PM Alembic informs about details of loss of certificate 4 Dec, 4:32 PM Alembic informs about loss of share certificates 17 Nov, 5:07 PM Alembic informs about loss of share certificates 16 Oct, 4:26 PM Alembic informs about appointment of independent director 11 Aug, 10:10 AM Alembic informs about voting results and scrutinizers' report 11 Aug, 10:09 AM Alembic informs about board decision 10 Aug, 5:06 PM Alembic - Quaterly Results 10 Aug, 4:07 PM Alembic - Quaterly Results 10 Aug, 4:07 PM Alembic informs about loss of share certificates 31 Jul, 2:21 PM Alembic informs about loss of share certificates 24 Jul, 12:20 PM Alembic informs about loss of share certificate 20 Jul, 2:09 PM

Alembic Stock Price Analysis and Quick Research Report. Is Alembic an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Alembic and its performance over the period of time. Alembic stock price today is Rs 118.72.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Alembic cash from the operating activity was Rs 81.0345 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Alembic has a Debt to Equity ratio of 0.0169 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Alembic , the EPS growth was 52.8142 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Alembic has OPM of 41.7774199131453 % which is a good sign for profitability.
     
  • ROE: Alembic have a average ROE of 17.082 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Alembic is Rs 118.72. One can use valuation calculators of ticker to know if Alembic share price is undervalued or overvalued.
Last Updated on:
Brief about Alembic

Alembic Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Alembic Ltd. is one of the leading pharmaceutical companies in India. With a rich history spanning over a century, the company has established itself as a key player in the healthcare industry. Founded in 1907, Alembic has consistently focused on innovation, research, and development to bring high-quality and affordable medicines to people across the globe.

Alembic Ltd. - Share Price

The share price of Alembic Ltd. reflects the market valuation of the company's stock. As a long-term investor, it is essential to analyze the share price trends over a period of time, taking into account factors such as market conditions, company performance, and industry outlook. Our website provides a detailed stock analysis page, where you can track Alembic Ltd.'s share price along with various technical indicators.

Alembic Ltd. - Balance Sheet

Analyzing a company's balance sheet is crucial for understanding its financial health. Alembic Ltd.'s balance sheet showcases its assets, liabilities, and shareholders' equity. By studying this financial statement, investors can gauge the company's liquidity, solvency, and ability to generate profits. Our website offers pre-built screening tools that enable you to perform a comprehensive analysis of Alembic Ltd.'s balance sheet.

Alembic Ltd. - Annual Report

The annual report of Alembic Ltd. provides valuable insights into the company's performance, strategy, and future prospects. It is a comprehensive document that includes financial statements, management discussion and analysis, and other relevant information. As a long-term investor, reviewing the annual report can help you make informed decisions. You can easily access and download Alembic Ltd.'s annual reports from our website.

Alembic Ltd. - Dividend

Dividends are an important aspect of a company's financial strength and shareholder returns. Alembic Ltd. has a consistent track record of rewarding its shareholders through regular dividend payments. By analyzing the dividend history, investors can assess the company's stability and commitment to sharing profits with its shareholders. Our website provides dividend-related information and tools to help you evaluate Alembic Ltd.'s dividend history.

Alembic Ltd. - Quarterly Result

Tracking a company's quarterly results is crucial for understanding its performance and growth trajectory. Alembic Ltd.'s quarterly results provide insights into its revenue, expenses, and profitability on a quarterly basis. By analyzing these results, investors can monitor the company's operational efficiency and financial stability. Our website offers pre-built screening tools that allow you to easily access and analyze Alembic Ltd.'s quarterly results.

Alembic Ltd. - Stock Price

The stock price of Alembic Ltd. is determined by market forces and reflects the perceived value of the company. Analyzing the stock price trends can provide valuable insights into market sentiment and investor expectations. Our website provides a stock analysis page with detailed information on Alembic Ltd.'s stock price, technical indicators, and performance relative to its peers.

Alembic Ltd. - Price Chart

Price charts are powerful tools that help investors visualize the historical movement of a stock's price. Alembic Ltd.'s price chart captures the fluctuations in its stock price over a specific period. By analyzing the price chart, investors can identify patterns, trends, and support/resistance levels. Our website offers pre-built screening tools that include price charts, allowing you to analyze and interpret Alembic Ltd.'s price movements.

Alembic Ltd. - News

Staying updated with the latest news and developments related to Alembic Ltd. is essential for making informed investment decisions. Our website provides a dedicated news section where you can find the latest news articles, press releases, and market updates related to Alembic Ltd. With access to reliable news sources, investors can stay ahead of market trends and gain a deeper understanding of the company's performance.

Alembic Ltd. - Concall Transcripts

Concall transcripts provide valuable insights into the discussions, decisions, and future plans of a company's management. By analyzing Alembic Ltd.'s concall transcripts, investors can gain a deeper understanding of the company's strategy, outlook, and risk factors. Our website provides downloadable concall transcripts, allowing you to stay informed about Alembic Ltd.'s management discussions.

Alembic Ltd. - Investor Presentations

Investor presentations are an important source of information for understanding a company's business model, growth strategy, and financial performance. Alembic Ltd.'s investor presentations provide a comprehensive overview of the company, including its operations, financials, and future prospects. Our website offers downloadable investor presentations, enabling investors to access and analyze Alembic Ltd.'s key investment highlights.

Alembic Ltd. - Promoters

Promoters play a crucial role in the success and growth of a company. Alembic Ltd. has a strong promoter group that has been instrumental in the company's journey. Our website provides detailed information about Alembic Ltd.'s promoters, their background, and their contributions to the company's success. Understanding the promoters' track record and vision can provide valuable insights for long-term investors.

Alembic Ltd. - Shareholders

Analyzing a company's shareholder base can provide insights into its ownership structure and investor sentiment. Alembic Ltd. has a diverse group of shareholders, including retail and institutional investors. Our website offers information about Alembic Ltd.'s major shareholders and their holdings. Understanding the shareholder composition can help investors gauge market confidence and assess the level of institutional support for the company.

At our website, we provide premium features that offer advanced tools for fair value calculation, including DCF analysis, BVPS analysis, earnings multiple approach, and DuPont analysis. These tools enable long-term investors to evaluate Alembic Ltd.'s intrinsic value, assess its financial performance, and make informed investment decisions.

In addition, we offer a wide range of downloadable resources, including annual reports, concall transcripts, investor presentations, credit ratings, and research reports. These resources provide comprehensive information and analysis to help investors thoroughly evaluate Alembic Ltd. and make informed investment decisions.

Please note that this content is written in a technical tone and is specifically geared towards long-term stock investors looking for stock analysis. 

Alembic Company's Reserves Trend

Alembic's reserves reflected a positive trend until Mar 2022, reaching a peak of Rs 962.49 Cr, before witnessing a slight downturn in the subsequent years down to Rs 757.40 Cr in Mar 2024. This indicates the company's retained earnings could have been affected by various operational and strategic maneuvers in recent fiscal years.

The Stability of Alembic's Balance Sheet

Over the years from Mar 2020 to Mar 2024, Alembic's balance sheet showcases a steady share capital at Rs 51.36 Cr, with total liabilities and assets balancing out each year. The Mar 2024 figures demonstrate total liabilities and assets at Rs 951.40 Cr, signaling a consistent foundation in the company's financial structure.

Alembic's Debt Introduction

Notably, Alembic introduced borrowings in Mar 2024, at Rs 7.39 Cr. This is a new development in the company's financing strategy, as it maintained a zero-borrowing stance in previous years. This could reflect a shift towards leveraging for growth or investment opportunities.

Assets Management by Alembic

Alembic has managed its assets with slight variations over the observed periods. While net block assets decreased marginally to Rs 130.54 Cr by Mar 2024, investments were significantly reduced from a high of Rs 702.38 Cr in Mar 2022 to Rs 399.78 Cr in Mar 2024. Such changes may be a result of asset reallocation or divestment strategies.

This analysis is based on the Standalone Balance Sheet of the company. In the ever-evolving stock market, this data remains integral for investors tracking performance on NSE/BSE indices, forming a crucial part of stock screening processes.

Read More
X